14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for EXAS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 65.03 4.77 %
R2 64.07 3.22 %
R1 63.47 2.26 %
Current price: 62.07
Support S1 61.54 -0.85 %
S2 60.95 -1.81 %
S3 59.98 -3.36 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 73.74 18.80 %
R2 72.95 17.53 %
R1 69.06 11.26 %
Current price 62.07
Support S1 60.70 -2.21%
S2 59.49 -4.16%
S3 57.53 -7.31%

EXAS Predictions History

5 years ago
NameNotImportant predicted that EXAS for 2019-05-03 is going $99.10 (-5.37%)

5 years ago
PumpTheseNumbers predicted that EXAS for 2019-03-19 is going $92.05 (0.99%)

5 years ago
Nate predicted that EXAS for 2019-03-19 is going $90.39 (-0.83%)

Rank:

5 years ago
Chaser predicted that EXAS for 2019-03-18 is going $97.18 (2.08%)

5 years ago
Chaser predicted that EXAS for 2019-02-25 is going $93.55 (1.64%)

6 years ago
mitch.bagdigian.10816 predicted that EXAS for 2017-10-03 is going $47.54 (-3.22%)

6 years ago
Victor..Li.8930 predicted that EXAS for 2017-07-24 is going $39.36 (-0.20%)

6 years ago
JuanC Villegas predicted that EXAS for 2017-07-24 is going $39.72 (1.40%)

6 years ago
JS predicted that EXAS for 2017-07-24 is going $38.76 (-1.05%)

6 years ago
JS predicted that EXAS for 2017-06-13 is going $32.04 (-0.90%)

Click to get the best stock tips daily for free!

About EXACT Sciences Corporation

EXACT Sciences Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid th... EXAS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT